Home›Companies›Biotech & Pharma›Navrogen

Navrogen Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 28, 2024·Suggest an edit

About Navrogen

Navrogen is a private company based in Cheyney, Pennsylvania. It has reported $12,801,161 raised in three offerings on Form D since October 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 5, 2024Jun 27, 2024amended Jun 28, 2024$542,000of $1.0M target13$41,692Convertible DebtRule 506(b)Form D/A ↗1 earlier filing
Jul 29, 2021Aug 12, 2021amended Feb 27, 2023$9,059,161of $9.2M target20$452KEquity, Series Seed Preferred StockRule 506(b)Form D/A ↗1 earlier filing
Oct 10, 2018Oct 23, 2018amended Sep 23, 2019$3,200,000fully sold18$177Kconvertible debtRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$12,801,161

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Navrogen's Form D filed Jun 28, 2024.

AB
LG
Luigi Grasso
Executive officer and director
NN
Nicholas Nicolaides
Executive officer and director

Earlier filings also listed Steven Kyriakos (executive officer, last listed Sep 2019).

Sources

  1. SECNavrogen Inc. Form D, filed Jun 27, 2024
  2. SECNavrogen Inc. Form D, filed Aug 12, 2021
  3. SECNavrogen Inc. Form D, filed Oct 23, 2018
  4. SECNavrogen Inc. filing history